Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X4VN
|
|||
Former ID |
DNC005576
|
|||
Drug Name |
6-(3-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol
|
|||
Synonyms |
CHEMBL193727; 6-(3-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol; SCHEMBL3924993; QTDYCKGQBCKMGC-UHFFFAOYSA-N; ZINC13645068; BDBM50168372
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H11FO2
|
|||
Canonical SMILES |
C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C=C3)O)F
|
|||
InChI |
1S/C16H11FO2/c17-15-9-13(4-6-16(15)19)10-1-2-12-8-14(18)5-3-11(12)7-10/h1-9,18-19H
|
|||
InChIKey |
QTDYCKGQBCKMGC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity. J Med Chem. 2005 Jun 16;48(12):3953-79. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.